天澤信息(300209.SZ):中住集團已降為公司第二大股東
格隆匯 2 月 9日丨天澤信息(300209.SZ)公佈,公司股東無錫中住集團有限公司(“中住集團”)於2020年2月5日被動減持所持公司股份44.6891萬股,佔公司總股本的0.11%。
此次被動減持前,中住集團持有公司股份4400.0466萬股,佔公司總股本的10.38%,為公司第一大股東。此次被動減持後,中住集團持有公司股份4355.3575萬股,佔公司總股本的10.28%;根據持股數量,中住集團已降為公司第二大股東。
公司控股股東、實際控制人肖四清持有公司股份4394.6759萬股,佔公司總股本的10.37%,成為公司第一大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.